Chemoinformaics analysis of 1-ACETYLOXYETHYL ACETATE
| Molecular Weight | 146.142 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.062 | nRig | 1 |
| Exact Molecular Weight | 146.058 | nRing | 0 |
| Solubility: LogS | -5.772 | nHRing | 0 |
| Solubility: LogP | 5.615 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 19.8959 |
| nHD | 0 | BPOL | 15.2401 |
| QED | 0.385 |
| Synth | 1.701 |
| Natural Product Likeliness | 0.244 |
| NR-PPAR-gamma | 0.086 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.295 |
| Pgp-sub | 0.005 |
| HIA | 0.002 |
| CACO-2 | -4.576 |
| MDCK | 0.0000212 |
| BBB | 0.371 |
| PPB | 0.967685 |
| VDSS | 0.91 |
| FU | 0.0252668 |
| CYP1A2-inh | 0.958 |
| CYP1A2-sub | 0.23 |
| CYP2c19-inh | 0.715 |
| CYP2c19-sub | 0.111 |
| CYP2c9-inh | 0.477 |
| CYP2c9-sub | 0.853 |
| CYP2d6-inh | 0.09 |
| CYP2d6-sub | 0.076 |
| CYP3a4-inh | 0.399 |
| CYP3a4-sub | 0.107 |
| CL | 8.811 |
| T12 | 0.498 |
| hERG | 0.223 |
| Ames | 0.005 |
| ROA | 0.055 |
| SkinSen | 0.939 |
| Carcinogencity | 0.127 |
| EI | 0.98 |
| Respiratory | 0.728 |
| NR-Aromatase | 0.044 |
| Antiviral | No |
| Prediction | 0.966442 |